tailieunhanh - Pharmaceutical Substances Syntheses, Patents, Applications - Part 108

Pharmaceutical Substances Syntheses, Patents, Applications - Part 108. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers | Indinavir sulfate I 1071 XVI------------------------------- 1. L-tartaric acid XVII S S-Mn H salen CI NoOCI. XIV ------------------------------------------- 4- 3-phenylpropyl pyridine N-axide XVIII oleum HjC-CN XVII XVI -------- XVIII dioxygenase bio-conversion --------------- 1S 2R -XVI1I Reference s a WO 9 309 096 Merck Co. appl. USA-prior. . b WO 9 502 583 Merck Co. appl. USA-prior. . c Askin D. et al. Tetrahedron Lett. TELEAY 35 4 673 1994 . WO 9 502 584 Merck Co. appl. USA-prior. . d Maligres . et al. Tetrahedron Lett. TELEAY 36 2195 1995 . e WO 9 716 450 Merck Co. appl. USA-prior. . f US 5 413 999 Merck Co. appl. USA-prior. . g WO 9 628 439 Merck Co. appl. USA-prior. . aa WO 9 636 629 Merck Co. appl. USA-prior. . WO 9 521 162 Merck Co. appl. USA-prior. . ab GB 2 302 690 Merck Co. appl. GB-prior. USA-prior. . ba WO 9 636 724 Merck Co. appl. USA-prior. . US 5 449 830 Merck Co. Procter Gamble Co. appl. USA-prior. . bb W0 9 700 966 Merck Co. appl. USA-prior. . WO 9 612 818 Merck Co. appl. USA-prior. . reductive amination with pyridinecarboxaldehyde US 5 508 404 Merck Co. appl. USA-prior. . prodrugs of indinavir . WO 9 514 016 Merck Co. appl. USA-prior. . combination with AZT WO 9 623 509 Merck Co. appl. USA-prior. . WO 9 604 913 Merck Co. appl. USA-prior. 1995 . combination with e. g. neoarapine WO 9 600 068 Merck Co. appl. USA-prior. . combination with quinoxalines EP 728 481 Bayer AG appl. D-prior. . Formulation s cps. 200 mg 400 mg as sulfate 1072 I Indobufen Trade Name s D Crixivan Merck Sharp GB Crixivan